Lamivudine/nevirapine/zidovudine

Source: Wikipedia, the free encyclopedia.
Lamivudine/nevirapine/zidovudine
Combination of
Lamivudinenucleoside reverse transcriptase inhibitor
Nevirapinenon-nucleoside reverse transcriptase inhibitor
Zidovudinenucleoside reverse transcriptase inhibitor
Clinical data
Trade namesDuovir-N, Zidovex-LN, others[1]
ATC code
Identifiers
CAS Number
ChemSpider
  • none

Lamivudine/nevirapine/zidovudine (3TC/NVP/AZT) is a

pregnant.[2] It is taken by mouth twice a day.[2]

The medication is generally well tolerated.

liver problems.[1] Use in pregnancy and breastfeeding appear to be safe.[1] The combination tablet is typically not appropriate for children.[2]

It is on the World Health Organization's List of Essential Medicines.[3] The combination is not commercially available in the United States as of 2018.[4]

See also

References

  1. ^ a b c d e "Nevirapine, zidovudine and lamivudine" (PDF). aidsmap. Archived from the original (PDF) on 20 December 2016. Retrieved 18 December 2016.
  2. ^ .
  3. . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  4. ^ "Drugs@FDA: FDA Approved Drug Products". www.accessdata.fda.gov. Retrieved 6 January 2018.